Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd

₹ 76.3 -4.40%
20 Dec - close price
About

Incorporated in 2008, Niva Bupa Health Insurance Ltd is Tech driven leading health insurer in India.[1]

Key Points

Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.

  • Market Cap 13,935 Cr.
  • Current Price 76.3
  • High / Low 109 / 69.2
  • Stock P/E 170
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 4.85 %
  • ROE 5.69 %
  • Face Value 10.0

Pros

Cons

  • Company has a low return on equity of -3.86% over last 3 years.
  • Earnings include an other income of Rs.221 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Insurance Industry: Finance & Investments

Part of BSE IPO

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 Jun 2024 Sep 2024
969 1,124 1,321
1,027 1,228 1,387
Operating Profit -58 -103 -66
OPM % -6% -9% -5%
50 84 79
Interest 0 0 0
Depreciation 0 0 0
Profit before tax -8 -19 13
Tax % 0% 0% 0%
-8 -19 13
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,057 1,413 2,149 2,853 4,115
1,094 1,435 2,326 3,183 4,225
Operating Profit -37 -22 -177 -330 -110
OPM % -3% -2% -8% -12% -3%
0 0 7 374 221
Interest 4 6 0 0 0
Depreciation 21 22 27 32 29
Profit before tax -62 -50 -197 13 82
Tax % 0% 0% 0% 0% 0%
-62 -50 -197 13 82
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 43%
TTM: 44%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 54%
TTM: 553%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: -4%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1,126 1,350 1,409 1,511 1,700 1,718
Reserves -780 -773 -903 -683 351 344
0 0 250 250 250 250
891 1,322 1,983 2,799 3,891 4,840
Total Liabilities 1,237 1,899 2,738 3,877 6,192 7,151
39 46 49 52 58 0
CWIP 2 2 1 4 1 0
Investments 1,067 1,622 2,401 3,366 5,458 5,965
129 230 287 455 675 1,186
Total Assets 1,237 1,899 2,738 3,877 6,192 7,151

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
257 338 593 813
-374 -723 -829 -1,882
280 374 280 1,110
Net Cash Flow 164 -12 43 41

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 0 0 0 0 0
Inventory Days
Days Payable
Cash Conversion Cycle 0 0 0 0 0
Working Capital Days -270 -290 -298 -313 -298
ROCE % -10% -30% 1% 5%

Shareholding Pattern

Numbers in percentages

7 Recently
Nov 2024
55.98%
8.63%
9.57%
25.83%
No. of Shareholders 1,60,440

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents